Home › Rectal Cancer › Florida › Sarasota
Rectal Cancer clinical trials in Sarasota, FL
4 studies for Rectal Cancer are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecruitingPhase 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- First Physicians Group - Gastroenterology Obesity Medicine, Sarasota
- FPG - Surgical Oncology Clinics Gastrointestinal Oncology Surgery, Sarasota
- Sarasota Memorial Hospital, Sarasota
- and 1 more
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- St. Louis, MO11 studies
- Columbus, OH10 studies
- Los Angeles, CA10 studies
- Seattle, WA9 studies
- Tampa, FL9 studies
- Nashville, TN9 studies
- Chicago, IL8 studies
- Rochester, MN8 studies
- Philadelphia, PA8 studies
Other studies in Sarasota
- Metastatic Cancer19 studies
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer16 studies
- Colorectal Cancer15 studies
- Endometrial Cancer15 studies
- Breast Cancer12 studies
- Cancer (all types)11 studies
- Triple-Negative Breast Cancer8 studies
- Atrial Fibrillation7 studies
- Lung Cancer7 studies
- Pancreatic Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.